Pathstone Holdings
HRMY icon

Pathstone Holdings’s Harmony Biosciences HRMY Stock Holding History

Pathstone Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+5,979
New +$189K ﹤0.01% 2204

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pathstone Holdings's HRMY Position: Q2 2026 in Review

Pathstone Holdings opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 5,979 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #2204 among its holdings.

326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Pathstone Holdings held 5,979 shares of Harmony Biosciences worth $218K as of Q2 2026.
  • Harmony Biosciences was a new Pathstone Holdings position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2204 holding.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.